bluebird bio BLUE reported its Q3 earnings results on Monday, November 7, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.
bluebird bio beat estimated earnings by 16.07%, reporting an EPS of $-0.94 versus an estimate of $-1.12.
Revenue was down $22.61 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.03 which was followed by a 22.05% increase in the share price the next day.
Here's a look at bluebird bio's past performance:
|Quarter||Q2 2022||Q1 2022||Q4 2021||Q3 2021|
To track all earnings releases for bluebird bio visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.